Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
05 May 2025
| Name: | LIFE THERAPEUTICS LIMITED (LFE) (This company subsequently changed its name and is now ARTURUS CAPITAL LIMITED. You should refer to that name for Status.) | ||||||
| Date of Listing: | 08 May 1986 | ||||||
| Subsequent Names: |
| ||||||
| Former Names: |
|
Stock Exchange Status:
This company subsequently changed its name and is now ARTURUS CAPITAL LIMITED. You should refer to that name for Stock Exchange Status.Legal Status:
This company subsequently changed its name and is now ARTURUS CAPITAL LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status:
This company subsequently changed its name and is now ARTURUS CAPITAL LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| ARTURUS CAPITAL LIMITED | 19/05/2009 | |
| LIFE THERAPEUTICS LIMITED | 30/12/2004 | 19/05/2009 |
| GRADIPORE LIMITED | 30/12/2004 |
REGISTRY:
Computershare Sydney
6 Hope St Ermington NSW 2115
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail
name changed to Arturus Capital Limited | 19/05/2009 |
shareholders met yesterday to approve a consolidation of the capital on the basis of one share (or option) for every four currently held | 07/05/2009 |
the securities will be suspended from quotation immediately at the request of the Company, pending compliance with listing rules | 06/05/2009 |
the suspension of trading in the securities of Life Therapeutics Limited (the "Company") will be lifted before the commencement of trading on Monday, 24 November 2008 following receipt of an announcement updating the market with respect to its change in activities to a general investment company | 21/11/2008 |
the securities of Life Therapeutics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, following the announcement that the Company has proposed to change the nature of its activities to a general investment company | 20/11/2008 |
securities reinstated to quotation | 26/03/2008 |
the Board advises it has received a formal offer from Investitori Associati SGR S.p.A (the ultimate owner of Kedrion) for the acquisition of all of the Company's collection centres | 17/03/2008 |
company releases its Half Yearly Report and Accounts | 14/03/2008 |
Dr. Jim Brown has tendered his resignation as Director of the company, effective immediately | 26/02/2008 |
the company today announces that there has been a significant adverse change in its financial position since its last announcement to the market regarding its financial position - it has accordingly agreed on terms with Octapharma AG ("Octapharma") regarding entry into a 5 year management agreement between the Company and Octapharma (shareholders should read the full release) | 25/02/2008 |
the securities will be suspended from quotation immediately at the request of the Company, pending the release of an announcement by the Company | 13/02/2008 |
we understand that on or about this date the company demerged NuSep Ltd by way of a 1 for 20 distribution | 15/12/2006 |
we understand that on or about this date the company made an in specie distribution of 1 share in NuSep Ltd for every 20 shares in the company | 15/12/2006 |
name changed from Gradipore Limited | 30/12/2004 |
name changed to Arturus Capital Limited | 19/05/2009 |
shareholders met yesterday to approve a consolidation of the capital on the basis of one share (or option) for every four currently held | 07/05/2009 |
the securities will be suspended from quotation immediately at the request of the Company, pending compliance with listing rules | 06/05/2009 |
the suspension of trading in the securities of Life Therapeutics Limited (the "Company") will be lifted before the commencement of trading on Monday, 24 November 2008 following receipt of an announcement updating the market with respect to its change in activities to a general investment company | 21/11/2008 |
the securities of Life Therapeutics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, following the announcement that the Company has proposed to change the nature of its activities to a general investment company | 20/11/2008 |
securities reinstated to quotation | 26/03/2008 |
the Board advises it has received a formal offer from Investitori Associati SGR S.p.A (the ultimate owner of Kedrion) for the acquisition of all of the Company's collection centres | 17/03/2008 |
company releases its Half Yearly Report and Accounts | 14/03/2008 |
Dr. Jim Brown has tendered his resignation as Director of the company, effective immediately | 26/02/2008 |
the company today announces that there has been a significant adverse change in its financial position since its last announcement to the market regarding its financial position - it has accordingly agreed on terms with Octapharma AG ("Octapharma") regarding entry into a 5 year management agreement between the Company and Octapharma (shareholders should read the full release) | 25/02/2008 |
the securities will be suspended from quotation immediately at the request of the Company, pending the release of an announcement by the Company | 13/02/2008 |
we understand that on or about this date the company demerged NuSep Ltd by way of a 1 for 20 distribution | 15/12/2006 |
we understand that on or about this date the company made an in specie distribution of 1 share in NuSep Ltd for every 20 shares in the company | 15/12/2006 |
name changed from Gradipore Limited | 30/12/2004 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Wayne Bellman | Chairman | |
| John Carlile | COO | |
| Simon Smith | CFO | |
| Mike Baronian | Non Exec Director | |
| Tony Izelaar | Non Exec Director | |
| Choon Lee | Non Exec Director | |
| John Manusu | Executive Director | |
| Dale Calhoun | Director | |
| James Gerard Story | Company Secretary |
Date of first appointment, title may have changed.
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
